title: Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors.
abstract: Virus-host interactions play key roles in promoting efficient egress of many RNA viruses, including Ebola virus (EBOV or "e") and Marburg virus (MARV or "m"). Late- (L-) domains conserved in viral matrix proteins recruit specific host proteins, such as Tsg101 and Nedd4, to facilitate the budding process. These interactions serve as attractive targets for the development of broad-spectrum budding inhibitors. A major gap still exists in our understanding of the mechanism of filovirus budding due to the difficulty in detecting virus-host complexes and mapping their trafficking patterns in the natural environment of the cell. To address this gap, we used a bimolecular complementation (BiMC) approach to detect, localize, and follow the trafficking patterns of eVP40-Tsg101 complexes in live mammalian cells. In addition, we used the BiMC approach along with a VLP budding assay to test small molecule inhibitors identified by in silico screening for their ability to block eVP40 PTAP-mediated interactions with Tsg101 and subsequent budding of eVP40 VLPs. We demonstrated the potential broad spectrum activity of a lead candidate inhibitor by demonstrating its ability to block PTAP-dependent binding of HIV-1 Gag to Tsg101 and subsequent egress of HIV-1 Gag VLPs.
authors.affiliation: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA.
authors.forename: Yuliang
authors.initials: Y
authors.lastname: Liu
authors.forename: Michael S
authors.initials: MS
authors.lastname: Lee
authors.forename: Mark A
authors.initials: MA
authors.lastname: Olson
authors.forename: Ronald N
authors.initials: RN
authors.lastname: Harty
references.citation: Methods Cell Biol. 2008;85:431-70
references.pmid: 18155474
references.citation: Nat Struct Biol. 2002 Nov;9(11):812-7
references.pmid: 12379843
references.citation: Cell Mol Life Sci. 2008 Mar;65(5):756-76
references.pmid: 18158582
references.citation: J Comput Chem. 2009 Dec;30(16):2785-91
references.pmid: 19399780
references.citation: J Virol. 2010 Jul;84(14):7053-63
references.pmid: 20463076
references.citation: J Virol. 2002 May;76(10):4855-65
references.pmid: 11967302
references.citation: J Virol. 2008 May;82(10):4884-97
references.pmid: 18321968
references.citation: Virol J. 2006 May 23;3:31
references.pmid: 16719918
references.citation: Nat Chem Biol. 2006 Jun;2(6):329-37
references.pmid: 16680159
references.citation: Virol J. 2005 Dec 20;2:92
references.pmid: 16367999
references.citation: J Virol. 2005 Apr;79(8):4709-19
references.pmid: 15795257
references.citation: J Virol. 2003 Apr;77(8):4794-804
references.pmid: 12663786
references.citation: Cell. 2001 Oct 5;107(1):55-65
references.pmid: 11595185
references.citation: Cell. 2001 Jul 27;106(2):145-55
references.pmid: 11511343
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18718-23
references.pmid: 18003913
references.citation: J Virol. 2010 Aug;84(15):7847-56
references.pmid: 20504928
references.citation: J Biol Chem. 2011 May 6;286(18):15854-61
references.pmid: 21454542
references.citation: J Virol. 2004 Jul;78(14):7344-51
references.pmid: 15220407
references.citation: BMC Bioinformatics. 2008 Feb 27;9:126
references.pmid: 18304355
references.citation: J Virol. 2010 Mar;84(5):2294-303
references.pmid: 20032189
references.citation: Nat Rev Mol Cell Biol. 2006 Jun;7(6):449-56
references.pmid: 16625152
references.citation: ACS Chem Biol. 2008 Dec 19;3(12):745-7
references.pmid: 19099395
references.citation: Virology. 2008 Dec 5;382(1):107-14
references.pmid: 18929379
references.citation: Antiviral Res. 2009 Mar;81(3):189-97
references.pmid: 19114059
references.citation: Virology. 2005 Jun 5;336(2):291-8
references.pmid: 15892969
references.citation: J Comput Chem. 2009 Jul 30;30(10):1545-614
references.pmid: 19444816
references.citation: J Gen Virol. 2010 Jan;91(Pt 1):228-34
references.pmid: 19812267
references.citation: Nat Biotechnol. 2002 Jan;20(1):87-90
references.pmid: 11753368
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
references.pmid: 15667143
references.citation: J Virol. 2011 Apr;85(7):3106-19
references.pmid: 21270170
references.citation: J Virol. 2007 May;81(9):4895-9
references.pmid: 17301151
references.citation: ACS Chem Biol. 2008 Dec 19;3(12):757-64
references.pmid: 19053244
references.citation: Assay Drug Dev Technol. 2003 Dec;1(6):811-22
references.pmid: 15090227
references.citation: J Virol. 2009 Mar;83(5):2327-37
references.pmid: 19091859
references.citation: Clin Lab Med. 2010 Mar;30(1):161-77
references.pmid: 20513546
references.citation: J Mol Graph Model. 2005 Apr;23(5):395-407
references.pmid: 15781182
references.citation: J Virol. 2003 Feb;77(3):1812-9
references.pmid: 12525615
references.citation: J Virol. 2011 Sep;85(17):8502-13
references.pmid: 21697477
references.citation: Am J Transl Res. 2009 Jan 05;1(1):87-98
references.pmid: 19966942
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6
references.pmid: 11095724
references.citation: J Virol. 2003 Sep;77(18):9987-92
references.pmid: 12941909
references.citation: J Med Chem. 2004 Jan 15;47(2):337-44
references.pmid: 14711306
references.citation: Virology. 2008 Mar 15;372(2):221-32
references.pmid: 18063004
references.citation: Antiviral Res. 2003 Jan;57(1-2):53-60
references.pmid: 12615303
references.citation: J Virol. 2003 Sep;77(17):9173-82
references.pmid: 12915533
references.citation: J Biol Chem. 2008 Oct 31;283(44):29822-30
references.pmid: 18723511
references.citation: Nat Med. 2001 Dec;7(12):1313-9
references.pmid: 11726971
references.citation: Mol Cell. 2002 Apr;9(4):789-98
references.pmid: 11983170
references.citation: Antiviral Res. 2009 Sep;83(3):245-51
references.pmid: 19523489
references.citation: J Mol Biol. 2003 Feb 14;326(2):493-502
references.pmid: 12559917
references.citation: J Infect Dis. 2011 Nov;204 Suppl 3:S817-24
references.pmid: 21987757